$CURR News - CURE Pharmaceutical Receives NSF's cG
Post# of 72711
Click here:
https://www.marketwatch.com/press-release/cur...re_twitter
About CURE Pharmaceutical Holding Corp.
CURE Pharmaceutical(R) is the pioneering developer of CUREform(TM), a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients.
CURE's delivery vehicles include CUREfilm(R), an advanced oral thin film; CUREpods(TM), a novel chewable liquid or solid delivery form; and CUREdrops(TM), an emulsion technology that can be incorporated into different dosage forms (film, tincture, beverages, etc.), among others.
CURE's clinical pipeline includes CUREfilm(R)Blue (sildenafil to treat erectile dysfunction), and CUREfilm(R)Canna (THC and CBD). Other OTC wellness products include Vitamin D, BCP Sleep, and Electrolytes. (Visit CURE's catalog for the complete list.) As a vertically integrated company, CURE's 25,000 square foot, FDA-registered, NSF(R) cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.